PharmiWeb.com - Global Pharma News & Resources

With recent advancements into Phase II and III trials for personalized cancer vaccines along with 437 other candidates in development, the biopharma industry is at a critical point to demonstrate safe and efficacious results that will offer a real hope for every patient with a cure for cancer.

The Personalized Cancer Vaccine Summit (formerly known as the mRNA Cancer Vaccine Summit) returns to Boston for the third year bringing together the top industry players developing individualized approaches across several modalities including mRNA, DNA, peptides, viral, dendritic cell and more to share how they are conquering common challenges, developing novel bioinformatic strategies, and achieving clinical efficacy.

Join the likes of BioNTech, CureVac, Imvax, NousCom and 80+ key stakeholders at the ultimate learning and networking forum to help you and your teams advance your patient-centric pipelines towards the clinic and regulatory approval.

 

Time: 8:00 AM - 5:00 PM